In this Contemporary OB/GYN® podcast, Dr. Lee P. Shulman discusses screening selectivity to reach high-risk populations, advantages of using an in-vitro blood test based on interferon-gamma release assay over a skin test with purified protein derivative, and appropriate treatment steps for patients testing positive.
Listen to the podcast now.